INCYTE CORPORATION Accrued Liabilities, Current
INCYTE CORPORATION (INCY) had Accrued Liabilities, Current of $1.09 billion as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-04-28
- 2026-03-31: Accrued Liabilities, Current $1.09B.
- 2025-12-31: Accrued Liabilities, Current $1.03B.
- 2025-09-30: Accrued Liabilities, Current $948.44M.
- 2025-06-30: Accrued Liabilities, Current $857.09M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $1.09B 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $1.03B 10-Q · filed 2026-04-28 | |
| 2025-09-30 | $948.44M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $857.09M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $1.38B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $1.21B 10-K · filed 2026-02-10 | |
| 2024-09-30 | $1.13B 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $1.03B 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $1.10B 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $935.57M 10-K · filed 2025-02-10 | |
| 2023-09-30 | $820.61M 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $810.85M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $825.44M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $701.05M 10-K · filed 2024-02-13 | |
| 2022-09-30 | $699.81M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $598.81M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $609.29M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $533.60M 10-K · filed 2023-02-07 | |
| 2021-09-30 | $481.88M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $413.07M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $420.88M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $378.40M 10-K · filed 2022-02-08 | |
| 2020-09-30 | $334.31M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $340.89M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $330.03M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $285.98M 10-K · filed 2021-02-09 | $285.95M 10-K · filed 2020-02-13 |
| 2019-09-30 | $249.72M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $210.47M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $211.30M 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $229.40M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $231.57M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $213.89M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $219.87M 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $198.90M 10-K · filed 2019-02-14 | |
| 2017-09-30 | $164.30M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $150.35M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $142.10M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $126.70M 10-K · filed 2018-02-15 | |
| 2016-09-30 | $112.60M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $102.18M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $133.64M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $86.53M 10-K · filed 2017-02-14 | |
| 2015-09-30 | $82.21M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $80.44M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $70.05M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $62.27M 10-K · filed 2016-02-12 | |
| 2014-09-30 | $54.24M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $50.88M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $56.95M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $46.06M 10-K · filed 2015-02-17 | |
| 2013-09-30 | $41.74M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $33.09M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $31.88M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $28.39M 10-K · filed 2014-02-21 | |
| 2012-09-30 | $22.75M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $25.11M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $25.11M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $24.77M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $19.84M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $20.05M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $16.83M 10-Q · filed 2011-05-03 | |
| 2010-12-31 | $15.70M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |